• Explore /
  • Poster
  • / <span>Contribution of the microbiome to differential drug efficacy and clinical trial outcomes between the US and Japan.</span>

Contribution of the microbiome to differential drug efficacy and clinical trial outcomes between the US and Japan.

Abstract Poster

Authors

Jie (James) Lam

Jie (James) Min Lam

BioCorteX Inc., New York, NY

Jie (James) Min Lam , Amedra Basgaran , Amanda Stafford , Eva Lymberopoulos , Mohammad Tanweer , Michael Hobbs , James Arney , Dionisios Korovilas , David Delanoue , Stephen Moore , Muhannad Alomari , Nikhil Sharma

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology

Track

Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology

Sub Track

Pharmacology/Pharmacodynamics/Pharmacogenetics

Citation

J Clin Oncol 42, 2024 (suppl 16; abstr 3086)

DOI

10.1200/JCO.2024.42.16_suppl.3086

Abstract #

3086

Poster Bd #

231

Abstract Disclosures

Similar Posters

First Author: Jun Ni

Poster

2022 ASCO Annual Meeting

Trends in treatment patterns associated with small cell lung cancer in a U.S. Medicare population.

Trends in treatment patterns associated with small cell lung cancer in a U.S. Medicare population.

First Author: Robert A. Ramirez

First Author: Pengbo Deng

First Author: Ming-Huang Chen